Molecular Diagnostics: A Revolutionary System to Improve Healthcare

MOLECULAR DIAGNOSTICS A Revolutionary System to Improve Healthcare Molecular diagnostic technologies include all tests and methods to identify a disease or the predisposition for a disease analyzing DNA or RNA of an organism. Molecular diagnostics is ready to get its due as the legitimate future business trend in healthcare. The genomic discovery will fuel the diagnostic market place because every gene-based therapeutic might need an accompanying molecular diagnostic test. Facts & information on Molecular Diagnostics It is used for a wide range of applications: Human clinical molecular diagnostic testing Human leukocyte antigen (HLÁ) typing Identity testing Forensic testing Veterinary molecular diagnostic testing 1st molecular diagnostics tests to reach the market were for infectious diseases and this remains the largest segment of the molecular diagnostics market. Other applications of molecular diagnostics in the fields of oncology, personalized medicine, inherited dis- orders and many other areas are rap- idly developing. Innovations in Molecular Diagnostics: EOSCAPE HIV -1 EOSCAPE TB-DST – RNA Test or EOSCAPE HIV is the new tool for HIV-1 viral load testing with unique combination of high performance and, robust operation and compact quantitative assay for identify- ing resistance to rifampicin and fluoroquinolone from sputum. For use in reflex testing model with EOSCAPE TB EOSCAPE instrumentation EOSCAPE HIV is a cartridge -format in vitro nucleic acid assay for the rapid detection and quantitation of human immunodeficiency virus type 1 (HIV-1)RNA EOSCAPE HIV RNA PLUS - qualitative assay measuring HIV RNA and DNA in circulating blood for diagnosing acute HIV infection and for early infant diagnosis EOSCAPE HBV DNA - quantitative assay measuring HBV DNA in circulating blood EOSCAPE HBV DNA PLUS - EOSCAPE HCV RNA - qualitative assay detecting presence of each of the six major HCV genotypes in whole blood quantitative assay simultaneously measuring HBV DNA in circulating blood and a panel of protein biomarkers relevant to HBV EOSCAPE TB - quantitative assay measuring TB bacterial DNA/RNA in sputum diagnosis and monitoring Using 100 microliter whole blood or plasma samples, typically from a finger stick or heel stick, the EOSCAPE HIV quantifies HIV RNA with sample in-results out time in less than 50 minutes EOSCAPE STD - quantitative assay detecting Chlamydia and gonorrhea in vaginal swabs Results are displayed on the integrated 18 cm touch screen display and over a variety of electronic communication protocols, including HL7, SMS and an optional attached printer ADVANTAGES: Reduced clinical Streamlined Faster simple acquisition laboratory infrastructure requirements turnaround time Why Molecular Diagnostics are important? CANCER DIAGNOSIS DIAGNOSIS OF INFECTIOUS DISEASES It spans the whole scope of cancer care molecular diagnostics is making it possible to detect infectious diseases and cancer more accurately at an earlier stage than before. Risk assessment Screening Differential diagnosis Staging Prognosis Therapy selection Therapy monitoring surveillance The technology is also optimizing testing for sexually transmitted diseases and genetic testing. Molecular diagnostics analyzes how these genes and proteins are interacting inside the cell. LUNG CANCER DIAGNOSIS The focus is on pattern in different types of cancerous or precancerous cells. The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad. HIV & AIDS DIAGNOSIS Molecular based technologies enable the sensitive identification of pathogens within a few hours and quantitative techniques are particularly valuable in the management of the chronic viral infections caused by HCV and HIV, when an assessment of viral load can be sued to guide therapies and prognosis. Similar to testing done in breast cancer, matching a cancer patient's molecular profile with the appropriate targeted therapy produces individualized treatment options. http://www.waves0.com rchardgoozh.blogspot.com diagnostics/importancehtml diagnosticsrevolution_orhype Published by: Richard Goozh http://www.prnewswire.com/news-releases/advances-in-molecul Hung-cancer-patients-201157241html 2]